Stock Price
4.40
Daily Change
0.20 4.76%
Monthly
11.68%
Yearly
92.14%
Q1 Forecast
4.10

Acasti Pharma reported $66.58M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acasti Pharma USD 66.58M 3.22M Sep/2025
Addus HomeCare USD 1.44B 14.37M Dec/2025
Amarin USD 659.81M 10.31M Sep/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Knight Therapeutics CAD 1.05B 10.63M Sep/2025
Option Care Health USD 3.46B 24.08M Dec/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025